Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain, Postoperative 4Pancreatic Neoplasms 3Lung Neoplasms 2Liver Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Thoracic Neuritis 1Stomach Neoplasms 1Reperfusion Injury 1Prostatic Neoplasms 1Neoplasms 1Leiomyoma 1Inflammation 1Endometrial Neoplasms 1End Stage Liver Disease 1Colonic Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Bites and Stings 1Biliary Tract Neoplasms 1Adenomyosis 1Acute Pain 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Analgesia, Patient-Controlled × Clear all
NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed
75 enrolled
Breast

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡